Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:330-332, doi:10.1016/j.jacc.2008.04.029
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenland, P.
Right arrow Articles by Lloyd-Jones, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Greenland, P.
Right arrow Articles by Lloyd-Jones, D.

VIEWPOINT AND COMMENTARY

Defining a Rational Approach to Screening for Cardiovascular Risk in Asymptomatic Patients

Philip Greenland, MD* and Donald Lloyd-Jones, MD, ScM

Departments of Preventive Medicine and Medicine, Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

Manuscript received March 31, 2008; revised manuscript received April 15, 2008, accepted April 21, 2008.

* Reprint requests and correspondence: Dr. Philip Greenland, Northwestern University, Feinberg School of Medicine, 750 North Lake Shore Drive, 9th Floor, Chicago, Illinois 60611.

Screening for coronary artery disease or for other forms of cardiovascular disease (CVD), is a superficially attractive idea that has been proposed by many cardiovascular experts. However, guidelines panels that employ medical outcomes and evaluation of a full range of benefits, risks, and harms of screening have repeatedly advised against the adoption of screening programs for CVDs. In this commentary, we discuss the limitations of the predictive capacity of selected cardiovascular screening tools. Possible harms and risks of screening tools are also discussed, and the conclusion is reached that available evidence does not provide support for adoption of a strategy of routine screening of asymptomatic people for CVD with available testing tools or devices. More evidence is needed to justify a policy of screening for CVD.

Key Words: atherosclerosis • imaging • screening

Abbreviations and Acronyms
  CAC = coronary artery calcium
  CAD = coronary artery disease
  CHD = coronary heart disease
  CVD = cardiovascular disease




This article has been cited by other articles:


Home page
Circ Cardiovasc ImagingHome page
P. Kaul and P. S. Douglas
Atherosclerosis Imaging: Prognostically Useful or Merely More of What We Know?
Circ Cardiovasc Imaging, March 1, 2009; 2(2): 150 - 160.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement